Article 4 Directions Are Quietly Making Existing HMOs More Valuable

What Article 4 Actually Does — and What It Doesn't

Article 4 Directions are a planning tool that removes specific permitted development rights in a defined area. For HMOs, the practical effect is this: converting a C3 dwelling (standard family home) into a C4 small HMO — typically 3 to 6 unrelated occupants — normally requires no planning permission at all. Article 4 strips that automatic right away.

Once a Direction is in place, any new C3-to-C4 conversion needs a full planning application. The council can approve it, refuse it, or attach conditions. That's a meaningful shift from "automatic" to "discretionary."

What Article 4 does not do is worth being equally clear about. It doesn't affect existing HMOs already operating before the Direction came into force — according to [hmobuilders.com](https://www.hmobuilders.com/blog/article-4-directions-hmo-investors-guide), those properties retain their established use. It doesn't change HMO licensing requirements, which run under a completely separate Housing Act 2004 regime. And it doesn't touch large HMOs of 7 or more occupants — those fall into the "sui generis" use class and have always required planning permission regardless.

So Article 4 specifically targets the mid-market: the 3-to-6 occupant HMO that represents the bread-and-butter of most UK HMO portfolios.

The Scale of the Rollout: 60+ Councils and Accelerating

The HMO Mortgage Broker's March 2026 licensing update confirms that more than 60 council areas across England now have Article 4 Directions in place for HMO conversions. That number has grown significantly since 2020, and the pace is accelerating.

The long-established areas read like a map of UK rental demand: Oxford (city-wide), Bristol (multiple wards with a 10% concentration threshold), Nottingham (city-wide, where approvals are reportedly rare), Leeds (multiple wards near universities), Manchester (Fallowfield, Withington, Rusholme), Brighton and Hove, York (city-wide, Direction confirmed in 2012 and documented in the [City of York Council SPD](http://www.york.gov.uk/downloads/file/2867/houses-in-multiple-occupation-draft-spd)), Cambridge, Birmingham (city-wide since June 2020), and Southampton (city-wide with a 10% concentration threshold within a 40-metre radius).

But the recent additions are where the story gets interesting for investors paying attention. According to [hmobuilders.com](https://www.hmobuilders.com/blog/article-4-directions-hmo-investors-guide), councils that introduced or confirmed Directions in 2025 and into 2026 include Bolton (June 2025, borough-wide, immediate effect), Wigan (August 2025), Walsall (October 2025), Halton (September 2025, immediate), Chorley (September 2025, immediate), Tameside (October 2025), Hillingdon (December 2025, borough-wide, immediate), Spelthorne (August 2025, phased), Medway, and Swale.

And just in February 2026, Telford and Wrekin Council confirmed an Article 4 Direction — set to take effect in February 2027 — that will require planning permission for all new HMO conversions across the borough, according to [residentiallandlord.co.uk](https://residentiallandlord.co.uk/telford-confirms-hmo-planning-controls-despite-just-200-consultation-responses/). Multiple London boroughs are also covered, including Waltham Forest, Redbridge, Newham, Hounslow, Hillingdon, Haringey, Ealing, and Barnet.

The direction of travel is unambiguous. Article 4 is becoming the default in high-demand rental markets, not the exception.

The Supply-Constraint Economics Behind the Premium

Here's the mechanism that matters for investors: Article 4 doesn't reduce demand for HMO accommodation. Student populations, young professionals, and lower-income households still need affordable shared housing. What Article 4 does is constrain the supply side — specifically, the rate at which new HMOs can enter the market.

In an Article 4 area, a would-be investor faces a planning application costing roughly £293 in fees alone (per [hmobuilders.com](https://www.hmobuilders.com/blog/article-4-directions-hmo-investors-guide)), plus professional fees for drawings and a planning statement, plus an 8-week minimum determination period that often runs longer, plus the genuine risk of refusal — particularly where concentration thresholds are close to their limits. Bristol's 10% threshold within 100 metres and Southampton's 10% within 40 metres are live examples of policies that routinely block new applications in established rental streets.

That friction doesn't stop determined investors, but it does deter marginal ones. And it meaningfully slows the rate at which new HMO supply enters the market.

Existing licensed HMOs in Article 4 areas sit outside this constraint entirely. They don't need retrospective planning permission. Their established use is protected. The HMO Mortgage Broker noted in its March 2026 update that experienced investors view established HMOs in Article 4 areas as "particularly attractive precisely because of this supply constraint." That's not marketing language — it's a straightforward reading of supply-side economics.

The acquisition premium for an existing licensed HMO in a restricted area reflects exactly this: buyers are paying not just for current income, but for the regulatory moat that makes it structurally difficult for competitors to replicate the asset. The trade-off is real — you pay more upfront, and you need to do thorough due diligence on licence compliance, room sizes, and any inherited issues with the property. But the barrier to competition is baked in from day one.

What This Means Practically — Three Scenarios

Thinking through the practical implications, there are three positions an investor might be in right now.

Scenario one: you already own a licensed HMO in an Article 4 area. Your asset has a structural advantage that didn't exist when you bought it, or has deepened since. The supply of competing HMOs in your area is constrained by the planning system. Demand from tenants is unlikely to fall — if anything, student and professional rental demand in restricted cities continues to grow. The question worth asking is whether your current rent reflects the scarcity value of your licence. If you haven't reviewed rents against the local market recently, now is the time.

Scenario two: you're looking to acquire an existing HMO in an Article 4 area. Expect to pay a premium — sellers know what they have. The due diligence checklist extends beyond standard property checks: verify the licence is current and transferable, confirm the property was operating as an HMO before the Article 4 Direction took effect, check room sizes against the council's minimum standards, and review whether the property would pass a licensing inspection. Consider consulting a qualified solicitor familiar with HMO law before exchange.

Scenario three: you're hoping to convert a property in an Article 4 area. This isn't impossible, but the bar is higher. Pre-application advice from the council — typically £50-£250 — is worth getting before you commit to a purchase. If the concentration threshold in that street is already close to the limit, no amount of good design will get you planning permission. Check the council's HMO register, calculate the percentage of properties within the relevant radius that are already licensed, and be honest about the odds before you proceed.

Telford's new Direction — confirmed February 2026, effective February 2027 — is a live example of why checking Article 4 status before purchase matters. Landlords who complete conversions before February 2027 are fine. Those who start after that date face the full planning process. The 12-month lead-in is a window, not a guarantee.

The councils implementing Article 4 Directions are not going to reverse course. The political pressure driving these decisions — concerns about housing mix, family home preservation, and community character — is increasing, not decreasing. If the 2025-2026 additions to the list (Bolton, Wigan, Walsall, Hillingdon, Telford) tell us anything, it's that the map of restricted areas will keep expanding. Investors who already hold licensed HMOs inside these boundaries are sitting on assets that are becoming harder to replicate by design. That's not a reason to be complacent about management, licensing compliance, or tenant experience — but it is a structural tailwind that most commentary on HMO investing fails to quantify. The moat is real. The question is whether you're inside it or still trying to get in.